AOBI Stock Price, Chart, Stats & News

American Oriental Bioengineering, Inc.
Save
American Oriental Bioengineering, Inc. (AOBI) does not currently pay a dividend.
949
Market cap
–
Current P/E
–
Forward P/E
AOBI chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
American Oriental Bioengineering, Inc. (AOBI), headquartered in Beijing, China, focuses its operations on the development, manufacturing, and commercialization of a broad spectrum of pharmaceutical and healthcare products. The company's core pharmaceutical offerings include a range of prescription medications. Among these are the Shuanghuanglian Lyophilized Injection Powder (SHL brand), prescribed to treat flu symptoms such as elevated fever, coughs, and sore throats, as well as to address upper respiratory tract infections, mild pneumonia, bronchitis, and tonsillitis.
Similar securities
Based on sector and market capitalization
Report issue





